A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer

NCT05780736 · clinicaltrials.gov ↗
TERMINATED
Status
33
Enrollment
INDUSTRY
Sponsor class

Stopped A decision was made to terminate the study due to expected timelines associated with start-up, participant enrollment, ethics committee approval and data availability from the study.

Conditions

Sponsor

Bristol-Myers Squibb

Collaborators